http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2581022-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b1c4bdddc1402bab1ba33a8e71558b1 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate | 2015-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_925859169bc536d034e4d68157c31ceb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f179b2e62e77103c3bf4c1f50c80bb8c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8182bb6322fdc84101a755276aba7060 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1798b554965c5c6f4d13dcd1c6635241 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d024080d072dd966117a51fffde99e96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9db80034dc98d242fbf58411eaf8745 |
| publicationDate | 2016-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2581022-C1 |
| titleOfInvention | Anticancer pharmaceutical compositions and method of treating breast cancer |
| abstract | FIELD: pharmaceutics. n SUBSTANCE: group of inventions refers to drugs, particularly to novel method of treating breast cancer, providing for parenteral administering therapeutically effective amount of (R)-4,11-dihydroxy-3-[(pyrrolidine-3-ylamino)methyl]-1H-naphto[2,3-f]indole-5,10-dione of formula I or its pharmaceutically acceptable salt. n n n n Further, group of inventions also refers to antitumour pharmaceutical compositions for parenteral use of compounds of formula I, containing compound I, pharmacologically acceptable carrier and one or more excipients specified in co-solvents, solubilisers, filling agents, emulsifiers, preservatives, antioxidants, buffer compounds, substances for maintaining isotonicity. n EFFECT: said compositions provide effective use of the compound I, because well soluble in water pharmacologically acceptable mediums, have high stability during storage in the form of lyophilisate, and in form of aqueous solutions. n 5 cl, 6 tbl, 4 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2712191-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2631100-C1 |
| priorityDate | 2015-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 73.